The future of monoclonal antibody delivery with Lipid Nanoparticles
The future of monoclonal antibody delivery with Lipid Nanoparticles Monoclonal antibodies (mAbs) have revolutionized modern medicine, offering targeted therapies for cancer, autoimmune diseases, and infectious diseases. However, their clinical potential is often hindered by challenges related to stability, bioavailability, and delivery efficiency. Traditional delivery [...]
